NCI-H838 [H838] from ATCC

Product Specs
ItemNCI-H838 [H838]
CompanyATCC
Price $551.00Supplier Page View Company Product Page
Catalog NumberCRL-5844
TypeCell Biology
SpeciesHomo sapiens
TissueLung
Cell LineNCI-H838
Validated Species ReactivityHuman (Hu)
Tissue (standardized)Lung
Age59 years
DiseaseAdenocarcinoma Non small cell lung cancer Stage 3B

Specifications/Features

Post freeze viability ≥ 50%

Add to Compare List

ATCC

10801 University Boulevard

Manassas, Virginia 20110-2209

United States

Phone: (703) 365-2700
Fax: (703) 365-2701

Company Profile

Website: http://www.atcc.org

(1) Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapyNat CommunApril 12, 2026Jana Samarin, Hana Nůsková, Piotr Fabrowski, Mona Malz, Eberhard Amtmann, Minerva J. Taeubert, Daniel Pastor-Flores, Daniel Kazdal, Roman Kurilov, Nicole de Vries, et al.CRL-5907) were cultivated in RPMI-1640 (Gibco). Other NSCLC cell lines (ATCC: A549 CRM-CCL-185 and NCI-H838 CRL-5844) were grown in low-glucose and high-glucose DMEM (Gibco), respectively. Resistance to cisplatin in H69CPR

(2) The nuclear receptor NR6A1 plays an oncogenic role through reprogramming glycolysis in tumorsBiological ResearchNovember 11, 2025Xiaowen Liu, Ye Li, Xinxu Rao, Shun Xie, Zhuoxian Rong, Lifang Yang, Zenghui enghui Mao, Dan Licervical cancer line HeLa (ATCC® CRM-CCL-2) and the intrahepatic bile duct cancer cell line TFK1 (ATCC® CRL-5844) were cultured in Dulbecco’s modified Eagle’s medium (DMEM, HyClone, USA) supplemented with 10% heat-inactivated

(3) Rational Engineering of a Brevinin-2 Peptide: Decoupling Potency from Toxicity Through C-Terminal Truncation and N-Terminal Chiral SubstitutionAntibiotics (Basel)August 1, 2025Aifang Yao, Zeyu Zhang, Zhengmin Song, Yi Yuan, Xiaoling Chen, Chengbang Ma, Tianbao Chen, Chris Shaw, Mei Zhou, Lei WangB2OS and its analogues. The human cancer cell lines, non-small-cell lung cancer cell line, H838 (ATCC® CRL-5844™), human prostate carcinoma cell line, PC-3 (ATCC® CRL-1435™), human breast cancer cell line, MCF-7

(4) Targeting transcription factors through an IMiD independent zinc finger domainEMBO Molecular MedicineMay 14, 2025Bee Hui Liu, Miao Liu, Sridhar Radhakrishnan, Meng-Yuan Dai, Chaitanya Kumar Jaladanki, Chong Gao, Jing Ping Tang, Kalpana Kumari, Mei Lin Go, Kim Anh L Vu, et al.SNU387 (CRL-2237), THLE2 (CRL-2706), THLE3 (CRL-3583), A549 (CRM-CCL-185), H1299 (CRL-5803), H838 (CRL-5844), H552 (CRL-5810), H2030 (CRL-5914), and H661 (HTB-183)) were obtained from ATCC and grown according

(5) Pan-KRAS inhibitors BI-2493 and BI-2865 display potent anti-tumor activity in tumors with KRAS wild-type allele amplificationMolecular Cancer TherapeuticsApril 2, 2025Antonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti, Johannes Popow, Florian Ebner, Daniel Gerlach, Antonia Geyer, Valeria Santoro, Andrew S. Boghossian, Matthew G. Rees, et al.00478, RRID: CVCL_5065, MycoAlert September 01, 2022, STR profile September 21, 2022), NCI-H838 (ATCC CRL-5844, RRID: CVCL_159, MycoAlert May 22, 2019, STR profile October 15, 2019), NCI-H661 (ATCC HTB-183, RRID:

(6) A compendium of Amplification-Related Gain Of Sensitivity genes in human cancerNat CommunJanuary 27, 2025Veronica Rendo, Michael Schubert, Nicholas Khuu, Maria F. Suarez Peredo Rodriguez, Declan Whyte, Xiao Ling, Anouk van den Brink, Kaimeng Huang, Michelle Swift, Yizhou He, et al.Wald statistic of each gene in a set. Cell line information and tissue culture NCI-H838 (cat. no. CRL-5844; ATCC; male), NCI-H1650 (cat. no. CRL-5883; ATCC; male), SK-LU-1 (cat. no. HTB-57; ATCC; female), ZR-75-1

(7) Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele AmplificationMol Cancer TherDecember 21, 2024Antonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti, Johannes Popow, Florian Ebner, Daniel Gerlach, Antonia Geyer, Valeria Santoro, Andrew S. Boghossian, Matthew G. Rees, et al.00478, RRID: CVCL_5065, MycoAlert September 01, 2022, STR profile September 21, 2022), NCI-H838 (ATCC CRL-5844, RRID: CVCL_159, MycoAlert May 22, 2019, STR profile October 15, 2019), NCI-H661 (ATCC HTB-183, RRID:

(8) Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancerCell Chemical BiologyDecember 19, 2024Sasikumar Kotagiri, Nicholas Blazanin, Yuanxin Xi, Yanyan Han, Md Qudratullah, Xiaobing Liang, Yawen Wang, Poonam Pandey, Hira Mazhar, Truong Nguyen Lam, et al.H1793 (Cat# CRL-5896, female), H2023 (Cat# CRL-5912, male), H1693 (Cat# CRL-5887, female), H838 (Cat# CRL-5844, male) were obtained from ATCC. Routine testing was performed to ensure cells were free of mycoplasma

(9) Label-Free Single-Cell Cancer Classification from the Spatial Distribution of Adhesion Contact KineticsACS SensorsNovember 22, 2024Balint Beres, Kinga Dora Kovacs, Nicolett Kanyo, Beatrix Peter, Inna Szekacs, Robert Horvathsolution. LCLC-103H human lung large cell carcinoma (ACC 384), H838 human lung adenocarcinoma (ATCC CRL-5844), and MDA-MB-231 and MCF-7 breast cancer cells were cultured in DMEM supplemented with 10% FBS (Biowest

(10) Inhibition of SARS-CoV-2 infection by Porphyromonas gingivalis and the oral microbiomeMicrobiology SpectrumOctober 3, 2024Alexander Bontempo, Alexandra Chirino, Alireza Heidari, Alexandra Lugo, Satoru Shindo, Maria R. Pastore, Riccardo Madonia, Sibel A. Antonson, Cristina Godoy, Frank C. Nichols, et al.with the approved guidelines. Mammalian cell cultures 293T (ATCC CRL-3216), ACE2 + 293, H838 (ATCC CRL-5844), and TZM.bl cells were cultured in DMEM complemented with 10% SBF and 2% Penicillin (5,000 U/mL)/Streptomycin

(11) Discovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteriaScientific ReportsAugust 13, 2024Fengting Liao, Zhuming Ye, Jinsheng Cheng, Jianhua Zhu, Xiaoling Chen, Xiaowei Zhou, Tao Wang, Yangyang Jiang, Chengbang Ma, Mei Zhou, et al.cancer cell lines were chosen for this study: human non-small cell lung cancer cell line, NCI-H838 (ATCC-CRL-5844); human glioblastoma astrocytoma cell line, U251MG (ECACC-09063001) and human breast cancer cell line

(12) Chimeric nanobody-decorated liposomes by self-assemblyNature NanotechnologyJune 1, 2024Md. Mofizur Rahman, Jing Wang, Guosheng Wang, Zhipeng Su, Yizeng Li, Yundi Chen, Jinguo Meng, Yao Yao, Lefei Wang, Stephan Wilkens, et al.(HTB-30), MDA-MB-231 (HTB-26), T24 (HTB-4), HT-29 (HTB-38), LS-174T (CL-188), NCI-N87 (CRL-5822), NCI-H838 (CRL-5844) and NCI-H2170 cells (CRL-5928) were maintained in Dulbecco’s modified Eagle medium supplied with 10%

(13) Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancersMolecular CellMay 16, 2024Chao Mao, Guang Lei, Amber Horbath, Min Wang, Zhengze Lu, Yuelong Yan, Xiaoguang Liu, Lavanya Kondiparthi, Xiong Chen, Jun Cheng, et al.lines,, HEK293T,ATCC,Cat#CRL-1573 HT-1080,ATCC,Cat#CCL-121 NCI-H292,ATCC,Cat#CRL-1848 HCC827,ATCC,Cat#CRL-2868 HEY-T30,ATCC,Cat#CRL-3252 NCI-N87,ATCC,Cat#CRL-5822 PC-3,ATCC,Cat#CRL-1435 T-47D,ATCC,Cat#HTB-133 T98G,ATCC,Cat#CRL-1690 DU 145,ATCC,Cat#HTB-81 NCI-H23,ATCC,Cat#CRL-5800 NCI-H460,ATCC,Cat#HTB-177 NCI-H838,ATCC,Cat#CRL-5844 NCI-H1437,ATCC,Cat#CRL-5872 NCI-H2126,ATCC,Cat#CCL-256 HeLa,ATCC,Cat#CCL-2 Experimental models:

(14) miR-147b mediated suppression of DUSP8 promotes lung cancer progressionOncogeneApril 1, 2024Turkowski K, Herzberg F, Günther S, Weigert A, Haselbauer T, Fink L, Brunn D, Grimminger F, Seeger W, Sültmann H, et al.fetal bovine serum (FBS; Gibco) and 1% penicillin-streptomycin (10,000 U/mL, Gibco). H838 cells (ATCC CRL-5844, American Type Culture Collection) and H1650 cells (ATCC CRL-5883, American Type Culture Collection)

(15) Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis InfectionBioconjugate ChemistryOctober 18, 2023Chiara Bellini, Emil Vergara, Fruzsina Bencs, Kinga Fodor, Szilvia Bősze, Denis Krivić, Bernadett Bacsa, Sára Eszter Surguta, József Tóvári, Rajko Reljic, et al.384),81,82 Calu-1 human epidermoid carcinoma (Sigma 93120818),83,84 H838 human lung adenocarcinoma (ATCC CRL-5844),85 and Vero-E6 African green monkey (Chlorocebus sabaeus) kidney epithelium cells (ECACC 85020206)

(16) Antioxidants stimulate BACH1-dependent tumor angiogenesisThe Journal of clinical investigationOctober 16, 2023Wang T, Dong Y, Huang Z, Zhang G, Zhao Y, Yao H, Hu J, Tüksammel E, Cai H, Liang N, et al.endpoint. Cell culture and reagents. The following human cell lines were used: A549 (CRL-7909, ATCC); H838 (CRL-5844, ATCC); ZFN-generated HIF1A-knockout (HIF1α–/–) and control (HIF1α+/+) A549 cells (CLLS-1014, MilliporeSigma);

(17) Discovery and analysis of a novel antimicrobial peptide B1AW from the skin secretion of Amolops wuyiensis and improving the membrane-binding affinity through the construction of the lysine-introduced analogueComputational and Structural Biotechnology JournalMay 6, 2023Haixin Qin, Weimin Zuo, Lilin Ge, Shirley W.I. Siu, Lei Wang, Xiaoling Chen, Chengbang Ma, Tianbao Chen, Mei Zhou, Zhijian Cao, et al.carcinoma cancer cells, PC-3 (ATCC®-CRL-1435TM), human non-small cell lung cancer cells, H838(ATCC®-CRL-5844), human glioblastoma/astrocytoma cancer cells, U251MG (ECACC-09063001), human microvascular endothelial cell

(18) Protocol for 3D screening of lung cancer spheroids using natural productsSLAS DiscoveryMarch 1, 2023Virneliz Fernández Vega, Dong Yang, Luis Ortiz Jordán, Fei Ye, Louis Conway, Li Yun Chen, Justin Shumate, Pierre Baillargeon, Louis Scampavia, Glauco Souza, et al.Materials h522 (ATCC, Part# CRL-5810)h226 (ATCC, Part# CRL-5826)h1838 (ATCC, Part# CRL-5899)h838 (ATCC, Part# CRL-5844)h2030 (ATCC Part# CRL-5914)h358 (ATCC Part# CRL-5807)Calu1 (ATCC, Part# HTB-54)HCC1171 (Korean Cell

(19) A Novel Strategy for the Design of Aurein 1.2 Analogs with Enhanced Bioactivities by Conjunction of Cell-Penetrating RegionsAntibiotics (Basel)February 19, 2023Fengting Liao, Yuping Chen, Anmei Shu, Xiaoling Chen, Tao Wang, Yangyang Jiang, Chengbang Ma, Mei Zhou, Tianbao Chen, Chris Shaw, et al.In this section, three cancer cell lines: human non-small-cell lung cancer cell line, NCI-H838 (ATCC-CRL-5844); human glioblastoma astrocytoma cell line, U251MG (ECACC-09063001) and human breast cancer cell line,

(20) De novo sphingolipid biosynthesis necessitates detoxification in cancer cellsCell reportsSeptember 27, 2022Spears ME, Lee N, Hwang S, Park SJ, Carlisle AE, Li R, Doshi MB, Armando AM, Gao J, Simin K, et al.RRID:CVCL_0317 "NCI-H838, Human Lung adenocarcinoma","Laboratory of David Sabatini (MIT, USA)",ATCC Cat#CRL-5844; RRID:CVCL_1594 "U-251MG, Human Astrocytoma","Laboratory of David Sabatini (MIT, USA)",RRID:CVCL_0021 "MDA-MB-231,

Be the First to Write a Review!

Description

Specifications/Features

ATCC

Citations (43)

Reviews

NCI-H838 [H838] from ATCC

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map